share_log

Morgan Stanley Maintains Equal-Weight on Organogenesis Hldgs, Lowers Price Target to $3

Benzinga ·  Aug 11, 2023 09:04

Morgan Stanley analyst Drew Ranieri maintains Organogenesis Hldgs (NASDAQ:ORGO) with a Equal-Weight and lowers the price target from $5 to $3.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment